EN | CN

ES008

HOME - OUR SCIENCE - Pipeline - ES008

ES008, a potential best-in-class asset, targets myloid immunesuppressive cells, promoting pro-inflammatory cytokine production and mediate M2 to M1 macrophage switch.


MOA:

Differentially expressed on myeloid lineage cells;
Promote differentiation of M2-like macrophages;
Distinct additional functional effects for potential differentiation of assets.